Denileukin Diftitox and Insulin Glargine (U-300) Pens
Determining the interaction of Denileukin Diftitox and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: denileukin diftitox
Brand name: Ontak
Synonyms: n.a.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Denileukin Diftitox-Insulin glargine and lixisenatide
- Denileukin Diftitox-Insulin glargine and lixisenatide Subcutaneous
- Denileukin Diftitox-Insulin glargine, recombinant Subcutaneous
- Denileukin Diftitox-Insulin glulisine
- Denileukin Diftitox-Insulin Glulisine (Cartridges and Pens)
- Denileukin Diftitox-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Denorex Extra Strength
- Insulin Glargine (U-300) Pens-Denorex Topical
- Insulin Glargine (U-300) Pens-Denosumab
- Insulin Glargine (U-300) Pens-Denosumab Injection (Prolia)
- Insulin Glargine (U-300) Pens-Denosumab Injection (Xgeva)
- Insulin Glargine (U-300) Pens-Denosumab Subcutaneous